Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial
- PMID: 16572419
- DOI: 10.1002/pbc.20820
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial
Abstract
Background: The EUROpean Ewing tumour Working Initiative of National Groups 1999 (EURO-E.W.I.N.G. 99) protocol prescribes six courses of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) as intensive induction chemotherapy for Ewing tumors (ET). Granulocyte-colony stimulating factor (G-CSF) is recommended. Adverse reactions (AR) were evaluated; quality assurance of data collection reviewed.
Procedure: Safety data from 4,746 courses of VIDE in 851 patients less than 50 years with ET were collected using a checklist and evaluated using descriptive statistics with sub-groups including gender, age, and tumor volume, analyzed by Wilcoxon and Kruskal-Wallis tests.
Results: Myelosuppression and infections were the major AR but with appropriate supportive therapy targeted dose intensity was maintained. Five VIDE-related deaths with three due to sepsis were reported. Renal and cardiac toxicity were reflected by glomerular filtration rate (GFR) <39 ml/min/1.73 m2 in 0.1%, tubular phosphate reabsorption < or = 0.80 in 1.9%, and left ventricular shortening fracture <28% in 2.5% VIDE courses. Statistically significant gender-associated AR concerning hemoglobin and platelets were observed with females > males as were age-associated AR concerning hemoglobin, WBC, platelets, stomatitis, and vomiting with AR decreasing with age, that is, children > adolescents > adults. No association of AR to tumor volume was found. In VIDE courses with and without G-CSF, neutropenia-related fever in 60.8% and 65.8%, and infection in 54.7% and 61.0% courses, respectively, were recorded.
Conclusions: AR under VIDE remained within the expected range. Some AR, for example, hematotoxicity were significantly influenced by age and gender but not by tumor volume. G-CSF did not significantly influence neutropenia-related fever and infection. Solicited safety collection with checklists adequately reflects the burden per course.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.J Clin Oncol. 2014 Aug 10;32(23):2440-8. doi: 10.1200/JCO.2013.54.4833. Epub 2014 Jun 30. J Clin Oncol. 2014. PMID: 24982464 Clinical Trial.
-
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.Cancer. 2002 Sep 15;95(6):1354-65. doi: 10.1002/cncr.10801. Cancer. 2002. PMID: 12216105
-
PATTERN OF CHEMOTHERAPY INDUCED TOXICITIES IN CHILDREN WITH EWING SARCOMA: A CASE SERIES.J Ayub Med Coll Abbottabad. 2024 Oct-Dec;36(4):816-820. doi: 10.55519/JAMC-04-13292. J Ayub Med Coll Abbottabad. 2024. PMID: 40121649
-
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.Int J Clin Oncol. 2024 Aug;29(8):1081-1087. doi: 10.1007/s10147-024-02572-6. Epub 2024 Jun 21. Int J Clin Oncol. 2024. PMID: 38904887
-
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.Semin Oncol. 1995 Jun;22(3 Suppl 7):18-22. Semin Oncol. 1995. PMID: 7541916 Review.
Cited by
-
Paley's multiplier method does not accurately predict adult height in children with bone sarcoma.Clin Orthop Relat Res. 2014 Aug;472(8):2506-13. doi: 10.1007/s11999-014-3636-4. Epub 2014 Apr 29. Clin Orthop Relat Res. 2014. PMID: 24777720 Free PMC article.
-
[Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):365-370. doi: 10.7499/j.issn.1008-8830.2309077. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38660900 Free PMC article. Chinese.
-
Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States.J Am Acad Orthop Surg Glob Res Rev. 2024 Oct 21;8(10):e24.00281. doi: 10.5435/JAAOSGlobal-D-24-00281. eCollection 2024 Oct 1. J Am Acad Orthop Surg Glob Res Rev. 2024. PMID: 39436736 Free PMC article.
-
Outcomes after interdisciplinary management of 7 patients with Askin tumor.Pediatr Surg Int. 2013 May;29(5):431-6. doi: 10.1007/s00383-013-3272-1. Epub 2013 Feb 10. Pediatr Surg Int. 2013. PMID: 23397588
-
Irinotecan and temozolomide chemotherapy in paediatric and adult populations with relapsed Ewing Sarcoma.Clin Transl Oncol. 2021 Apr;23(4):757-763. doi: 10.1007/s12094-020-02466-9. Epub 2020 Aug 5. Clin Transl Oncol. 2021. PMID: 32761317
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials